ASMB vs MSCI · rev $21.6M vs P/E 37, rev $1.72B
Assembly Biosciences Inc (ASMB) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Assembly Biosciences Inc (ASMB) is a biotechnology company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported ASMB revenue for 2026-06-30 was $21.6M. Net income was -$12.9M. ASMB currently screens at market cap $143.0M.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
ASMB currently screens at market cap $143.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the ASMB and MSCI stock pages for the full models.
Not investment advice.